Ignite Creation Date:
2025-12-25 @ 2:16 AM
Ignite Modification Date:
2026-01-07 @ 7:57 AM
Study NCT ID:
NCT03571360
Status:
UNKNOWN
Last Update Posted:
2020-06-11
First Post:
2018-06-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
CTA Expression/Methylation and Response to Pembrolizumab of NSCLC Patients
Sponsor:
Medical University of Vienna
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
2017-000689-30
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None